VGLL4: A Potential Drug Target and Biomarker (G9686)

Target Name: VGLL4

NCBI ID: G9686

VGLL4

VGLL4: A Potential Drug Target and Biomarker

Vestigial like family member 4 (VGLL4) is a gene that has been identified in various organisms, including humans. It has been annotated as a potential drug target and biomarker. In this article, we will explore the potential implications of VGLL4 as a drug target and biomarker.

Drug Target Potential

VGLL4 is a gene that has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. It is also known to be involved in the development and progression of various diseases, including cancer. Therefore, it is a promising target for drug development.

One of the potential drug targets for VGLL4 is the inhibition of its activity, as this could lead to the regression of cancer cells and the inhibition of their migration and invasion. This could be achieved through various mechanisms, such as blocking the VGLL4-FGF signaling pathway, which is known to be involved in cancer cell growth and progression.

Another potential mechanism for the inhibition of VGLL4 could be the inhibition of its expression. This could be achieved through the use of small molecules, such as inhibitors, or through the use of antibodies that target VGLL4 specifically.

Biomarker Potential

VGLL4 has also been identified as a potential biomarker for various diseases, including cancer. This is because its expression is often affected by the progression of these diseases. For example, it has been shown to be downregulated in various types of cancer, including breast, ovarian, and colorectal cancers.

Additionally, VGLL4 has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Therefore, it may also be a potential biomarker for these diseases.

Conclusion

In conclusion, VGLL4 is a gene that has been identified as a potential drug target and biomarker. Its expression is involved in various cellular processes, including cell adhesion, migration, and invasion, and it has been shown to be involved in the development and progression of various diseases, including cancer. Therefore, it is a promising target for drug development and a potential biomarker for various diseases. Further research is needed to fully understand its potential mechanisms of action and its potential as a drug and biomarker.

Protein Name: Vestigial Like Family Member 4

Functions: May act as a specific coactivator for the mammalian TEFs

The "VGLL4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VGLL4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets